Experience

Synklino

• Denmark
• Biotechnology Research
• 1 - 100 Employee

• Head of BD

  • Oct 2021 - Present



RL Biotech Consulting

• Lyon Area, France

• Owner / Founder

  • Jun 2018 - Present



Vernalis

• United Kingdom
• Biotechnology Research
• 100 - 200 Employee

• BD Consultant

  • Jun 2018 - Present

• Business Development Manager

  • Jan 2016 - May 2018

  Reporting to the CEO.Responsible for all out-licensing activities and collaborations

• Senior Analyst, Business Development

  • Aug 2013 - Dec 2015

  Reporting to the Business Development director.Out-licensing activities for the NCE pipeline, Oncology and CNS applications - Scientific and commercial competitive landscape - Financial valuation and deal structure - Attending partnering conferences - Involved in discussions with potential partners, confidential presentations and due diligence process - Fully-involved in the out-licensing of the adenosine receptor antagonist program to an undisclosed US partner : $1M upfront and more than $200M in development, regulatory and sales milestonesIn-licensing activities for the US commercial infrastructure - Screening of potential licensing opportunities - Building the business case : scientific and commercial landscape, fit with corporate strategy, financial valuation - Attending partnering conferencesCollaboration with the research group to develop new drug discovery partnerships - Screening of potential partners / prospection (network, LinkedIn, emails, conferences) - Presentation of the technology platform to potential partnersCough-cold portfolio - Sales forecasts and financial valuation of the CC portfolio - Commercial launch expected in 3Q2015 (US only)Oral presentations to the Exec team on a regular basis.



VC-backed / Stealth mode start up

• Copenhagen, Capital Region, Denmark

• Business Development Advisor

  • Nov 2020 - Jan 2022



Vaxine Pty Ltd

• Australia
• Biotechnology Research
• 1 - 100 Employee

• Business Development, Internship

  • Sep 2011 - Mar 2012

  Intern in Business Development. Vaxine is an Australia-based start-up, developing innovative adjuvants for the vaccine industry. Assist the CEO defining the development strategy: Valuation of new technology and new development opportunities. Assist the CEO in business development, including teleconferences with large pharmaceutical companies and animal health companies. Creation of commercial presentations, for both human and animal applications. Identification of partnership opportunities. Financial valuation of the company's technologies using different valuation methods (DCF, Real Options).



DIALPHA

• Région de Montpellier, France

• Business development, Internship

  • Feb 2011 - Jul 2011

  Strategic development of a service offer for preclinical studies in the field of metabolic diseases for nutraceuticals suppliers and agro-food companies. The position included: market analysis, definition of a marketing strategy, development of marketing tools and business development actions (phone, mailing, conferences). Strategic development of a service offer for preclinical studies in the field of metabolic diseases for nutraceuticals suppliers and agro-food companies. The position included: market analysis, definition of a marketing strategy, development of marketing tools and business development actions (phone, mailing, conferences).



I-Stem

• France
• Research Services
• 1 - 100 Employee

• Intern

  • Apr 2010 - Jul 2010

  Optimized the conditions of transduction to reprogram fibroblasts into induced pluripotent stem cells (iPSC) Optimized the conditions of transduction to reprogram fibroblasts into induced pluripotent stem cells (iPSC)